President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

The Trump Administration has promised not to cut Medicare and Medicaid benefits but that doesn’t mean it’s been leaving things alone there. Here’s what’s been happening at CMS.

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, ...

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

The Centers for Medicare & Medicaid Services on Friday rejected a Biden administration proposal to expand Medicare coverage of weight-loss drugs such as Eli Lilly's Zepbound and Novo Nordisk's ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access to weight-loss drugs paid for Medicare and Medicaid. By Margot Sanger ...

The Centers for Medicare and Medicaid Services said it would not cover the medications under Medicare’s Part D coverage.

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

Health and Human Services Secretary Robert F. Kennedy Jr. has been critical of the drugs, instead placing a focus on ...

Independence Health Group, the parent company of Independence Blue Cross, spent $500 million last year to provide ...

Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...

Popular weight loss drugs may do more than curb appetite — they may also help reduce the risk of dementia, according to new research.